|
|
 |
|
|
|
|
|
39 year old Hispanic man who presents with decreased vision OS for one year
Digital Journal of Ophthalmology 1996
Volume 2, Number 10
December 24, 1996
|
Printer Friendly
|
|
|
John A. Irvine, M.D. | Doheny Eye Institute, University of Southern California, Los Angeles, California Irene C. Kuo, M.D. | Doheny Eye Institute, University of Southern California, Los Angeles, California
|
|
|
| References | 1) Dana MR et al. Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Archives of Ophthalmology. 1995;112(5): 626-9.
2) Gelber RH Hansen's disease. Western Journal of Medicine. 1993; 158(6): 583-590.
3) Kaplan G. Recent advances in cytokine therapy in leprosy. Journal of Infectious Diseases. 1993; 167(1) Supplement 18-22.
4) Mannis MJ, Macsai MS, Huntley AC. Eye and Skin Diseases. Lippincott-Raven Publishers, Philadelphia, 1996.
5) Ostler H.B. Diseases of the External Eye and Adnexa. Williams & Wilkins, Baltimore, 1993:
6) Waddell KM Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage FROM leprosy in Uganda. British Journal of Ophthalmology. 1995; 79(3): 250-6.
7) Walthen PI Hansen's disease. Southern Medical Journal. 1996; 89(7): 647-652.
8) Leprosy. Report of a meeting of physicians and scientists at the All India Institute of Medical Sciences, New Delhi. Lancet. 1995; 345(8951): 697-703. | |
|
|
|
|
|
|
Welcome, please sign in 
